CUCCHIARA, MARTINA
 Distribuzione geografica
Continente #
EU - Europa 292
NA - Nord America 217
AS - Asia 45
AF - Africa 3
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 561
Nazione #
US - Stati Uniti d'America 214
IT - Italia 172
SG - Singapore 29
DE - Germania 23
FI - Finlandia 19
IE - Irlanda 19
SE - Svezia 16
CZ - Repubblica Ceca 9
AT - Austria 8
RU - Federazione Russa 8
GB - Regno Unito 6
CN - Cina 5
JP - Giappone 5
BE - Belgio 4
NG - Nigeria 3
NL - Olanda 3
NZ - Nuova Zelanda 3
CA - Canada 2
CH - Svizzera 2
PK - Pakistan 2
BD - Bangladesh 1
EU - Europa 1
GL - Groenlandia 1
HU - Ungheria 1
IN - India 1
LV - Lettonia 1
PH - Filippine 1
RS - Serbia 1
SA - Arabia Saudita 1
Totale 561
Città #
Milan 57
Ashburn 36
Chandler 31
Boardman 29
Singapore 29
Dublin 19
Como 16
Helsinki 14
Nyköping 14
Varese 11
Chicago 10
Gorgonzola 10
New York 10
Rome 10
Brno 9
Los Angeles 9
Magnago 9
Gallarate 7
Monza 6
Munich 6
Frankfurt am Main 5
Princeton 5
Tokyo 5
Vienna 5
Brussels 4
Fairfield 4
Santa Clara 4
Agege 3
Graz 3
Houston 3
Legnano 3
Seattle 3
Amsterdam 2
Auckland 2
Budrio 2
Dallas 2
Gavirate 2
Höri 2
Lappeenranta 2
London 2
San Diego 2
San Fermo della Battaglia 2
Southwark 2
Toronto 2
West Jordan 2
Wilmington 2
Woodbridge 2
Ann Arbor 1
Beijing 1
Belgrade 1
Chengdu 1
Cormano 1
Espoo 1
Gazipur 1
Genoa 1
Inzago 1
Manila 1
Napier City 1
Nuuk 1
Ogden 1
Pozzuolo Martesana 1
Prescot 1
Pune 1
Riga 1
Riyadh 1
Turin 1
Verona 1
Vicenza 1
Washington 1
Wuhan 1
Totale 442
Nome #
When a Friend Becomes Your Enemy: Natural Killer Cells in Atherosclerosis and Atherosclerosis-Associated Risk Factors 75
Neutrophil and Natural Killer Cell Interactions in Cancers: Dangerous Liaisons Instructing Immunosuppression and Angiogenesis 69
The cell-autonomous and non-cell autonomous activities of the alarmin-like RNASET2 protein in prostate cancer models 67
The tumor innate immune microenvironment in prostate cancer: an overview of soluble factors and cellular effectors 62
Metabolic Rewiring in the Tumor Microenvironment to Support Immunotherapy: A Focus on Neutrophils, Polymorphonuclear Myeloid-Derived Suppressor Cells and Natural Killer Cells 54
Circulating and tumor infiltrating natural killer cells in renal cancer patients express the CD9 and CD49a decidual markers and have increased activation of STAT3 47
Characterization of circulating and tumor infiltrating Natural Killer cells in patients with pancreatic ductal adenocarcinoma: polarization state and effects of TGFβRI blockade 36
Polarization of circulating and tumor infiltrating NK cells in prostate cancer: role of STAT3 28
Adipose mesenchymal stem cell-derived soluble factors, produced under hypoxic condition, efficiently support in vivo angiogenesis 25
The alarmin-like RNASET2 molecule exerts cell-autonomous and non-cell autonomous activities in prostate cancer models 25
Polarization of circulating and tumour infiltrating NK cells in prostate cancer: role of STAT3 23
Circulating Natural Killer cells in patients with symptomatic atherosclerosis acquire the CD9 + CD49a pro-inflammatory phenotype and support M1-like macrophage polarization 21
Circulating and tumour infiltrating NK cells acquire the decidual-like CD9+CD49a+ phenotype in pancreatic ductal adenocarcinoma: reversion by anti-fibrotic treatments 21
The alarmin-like RNASET2 proteins impacts on prostate cancer (PCa) cell proliferation and inflammatory properties and shape macrophage polarization in a prostate cancer (PCa) in vivo model 21
Immunoprofiling and immunoscoring in cor onary artery disease: From vascular research to the bedside? 12
The human RNASET2 protein behaves as an alarmin by stimulating chemotaxis and M1-polarization in vitro in two macrophage cell models 10
Dental pulp mesenchymal stem cell (DPSCs)-derived soluble factors, produced under hypoxic conditions, support angiogenesis via endothelial cell activation and generation of M2-like macrophages 3
Totale 599
Categoria #
all - tutte 3.976
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.976


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202244 0 0 0 0 4 0 7 16 6 5 1 5
2022/2023134 2 3 12 13 23 26 2 21 11 8 5 8
2023/2024261 31 14 21 49 43 22 5 4 4 37 1 30
2024/2025160 8 4 51 55 32 10 0 0 0 0 0 0
Totale 599